Noelle Perkins compensation by year
Cushman & Wakefield Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $278,846 | $580,000 | $599,462 |
| Bonus | $300,000 | $0 | $0 |
| Stock awards | $1,002,139 | $1,216,319 | $1,118,836 |
| Option awards | $0 | $0 | $0 |
| Non-equity incentive | $133,941 | $522,000 | $600,000 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $4,462 | $27,800 | $28,635 |
| Total | $1,719,388 | $2,346,119 | $2,346,933 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cushman & Wakefield Ltd. DEF 14A filed April 3, 2026, accession 0001628369-26-000046, and prior-year filings.
How this page was built: the Cushman & Wakefield Ltd. filed document, accession 0001628369-26-000046. Every figure is read from that document and cited to the page and table it appears in. Filed April 3, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 45,547 | $522,527 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Cushman & Wakefield Ltd.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
5 Form 4 lines since the FY2025 proxy (filed April 3, 2026)current to 2026-11-07 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-07-01 | Exercise or conversion derivative | — | 30,563 | $0.00 | 0 |
| 2026-07-01 | Tax withholding | — | 13,540 | $13.84 | 90,980 |
| 2026-07-01 | Exercise or conversion | — | 30,563 | $0.00 | 104,520 |
| 2026-07-01 | Exercise or conversion | — | 163,203 | $0.00 | 254,183 |
| 2026-07-01 | Tax withholding | — | 72,299 | $13.84 | 181,884 |
The 5 most recent of 5 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Cushman & Wakefield’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Michelle MacKay | Chief Executive Officer | $9,469,699 |
| Andrew McDonald | Global President & Chief Operating Officer | $5,780,389 |
| Neil Johnston | Executive Vice President & Chief Financial Officer | $3,464,254 |
| Noelle Perkins · this page | Executive Vice President, Chief Legal Officer & Secretary | $2,346,933 |
| Nathaniel Robinson | Executive Vice President, Chief Investment & Strategy Officer | $2,314,088 |
The full Cushman & Wakefield compensation record
free company briefThis page is one person within Cushman & Wakefield's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Cushman & Wakefield proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Cushman & Wakefield's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cushman & Wakefield's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.